Control of T Cell Fates and Immune Tolerance by P38α Signaling in Mucosal Dendritic Cells (P3177)

Gonghua Huang,Yanyan Wang,Hongbo Chi
DOI: https://doi.org/10.4049/jimmunol.190.supp.171.1
2013-01-01
The Journal of Immunology
Abstract:Abstract Dendritic cells (DCs) bridge innate and adaptive immunity. Our previous studies have shown that DCs employ the intracellular p38 and MKP-1 signaling axis to instruct T cell lineage choices and T cell-dependent autoimmune and infectious diseases (Huang et al. Immunity 2011; Huang et al. Nature Immunology 2012). Aside from launching protective adaptive immunity, DCs also play a crucial role in maintaining immune tolerance. To further explore the intracellular signaling pathways that program DCs to promote tolerogenic responses, we used a combination of approaches including mouse genetics, cellular immunology and biochemistry, as well as models of immune tolerance. We found that p38α signaling in mucosal DCs reciprocally regulated the differentiation of anti-inflammatory induced regulatory T (iTreg) cells and proinflammatory Th1 cells from naïve precursors, and promoted mucosal tolerance. Deficiency of p38α in mucosal DCs inhibited the generation of iTreg cells while promoting Th1 cell development in a TGF-β-dependent manner. Consequently, loss of p38α in DCs prevented induction of mucosal tolerance in vivo. Moreover, p38 signaling was constitutively activated in mucosal DCs and p38α activity was required for the expression of retinoid acid-metabolizing enzymes and imprinting gut homing receptors on responding T cells. Our studies identify a key mechanism of DC-mediated coupling of T cell differentiation and trafficking that orchestrates mucosal immune tolerance.
What problem does this paper attempt to address?